Quan Zhou
Director/Miembro de la Junta en Beijing Biostar Pharmaceuticals Co. Ltd. .
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Li Tang | M | 61 |
Beijing Biostar Pharmaceuticals Co. Ltd.
 Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 años |
| Kai Lin Liu | M | 41 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 4 años |
| Heng Xie | M | 65 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 años |
| Rong Guo Qiu | M | 62 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 años |
| Ri Xiang Kong | M | 47 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 21 años |
| Li Xin Wang | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 años |
| Shu Feng Zhang | M | 55 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 8 años |
| De Qing Tan | M | 57 |
Southwest Jiaotong University
| 22 años |
| Dong Ran | M | 38 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 1 años |
| Song Dong Meng | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 años |
| Cheng Zhang | M | 49 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 6 años |
| Zuo Ping Xiao | M | 49 |
Southwest Jiaotong University
| 17 años |
| Yik Pun Chan | M | 42 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | - |
| Pai Zhu | M | 31 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 años |
| Hui Wu Wang | M | 52 |
Southwest Jiaotong University
| 15 años |
| Guang Wu | M | 66 |
Southwest Jiaotong University
| 16 años |
| Fei Peng | M | 50 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Hong Yu Zhuo | M | 45 |
Southwest Jiaotong University
| 7 años |
| Lei Lei | M | 40 |
Southwest Jiaotong University
| 6 años |
| Shun Shen | M | 51 |
Southwest Jiaotong University
| 7 años |
| Yan Fang Xu | M | 56 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | - |
| Ying Wang | M | 56 |
Southwest Jiaotong University
| 3 años |
| Xing Zhang | M | 33 |
Southwest Jiaotong University
| 4 años |
| Xu Dong Chen | M | 57 |
Southwest Jiaotong University
| 3 años |
| Peng Wang | M | 43 |
Southwest Jiaotong University
| 3 años |
| Yu Peng Li | M | 41 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 años |
| Xian Jun Wang | M | 53 |
Southwest Jiaotong University
| 1 años |
| Yao Chao Chen | M | 39 |
Southwest Jiaotong University
| 4 años |
| Wu Li Gao | F | 40 |
Southwest Jiaotong University
| 4 años |
| Hua Wang | M | 37 |
Southwest Jiaotong University
| 4 años |
| Jing Xiang | M | 48 |
Southwest Jiaotong University
| 3 años |
| Yu Mao | M | 37 |
Southwest Jiaotong University
| 4 años |
| Hang Wei | M | 47 |
Southwest Jiaotong University
| 3 años |
| Xiao Li Shi | F | 38 |
Southwest Jiaotong University
| 4 años |
| Xiao Long Wu | M | 50 |
Southwest Jiaotong University
| 2 años |
| Sheng Xiang Lei | M | 59 |
Southwest Jiaotong University
| 3 años |
| Erke Huang | M | 36 |
Southwest Jiaotong University
| 4 años |
| Chun Hui Zhang | F | 37 |
Southwest Jiaotong University
| 3 años |
| Gang Wu | M | 46 |
Southwest Jiaotong University
| 4 años |
| Xin Pan | M | 36 |
Southwest Jiaotong University
| 4 años |
| Yong Ye | M | 49 |
Southwest Jiaotong University
| 3 años |
| Min Xiang | F | 52 |
Southwest Jiaotong University
| 4 años |
| Li Li Ding | F | 38 |
Southwest Jiaotong University
| 4 años |
| Jing Yu Jin | M | 58 |
Southwest Jiaotong University
| 3 años |
| Cha Hua Lin | F | 46 |
Southwest Jiaotong University
| 4 años |
| Yu Jiang Lu | M | 52 |
Southwest Jiaotong University
| 2 años |
| He Jiang | M | 58 |
Southwest Jiaotong University
| 1 años |
| Zhen Ling Wang | M | 43 |
Southwest Jiaotong University
| 4 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| China | 48 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Quan Zhou
- Red Personal